Mucin‐type O‐glycans in human colon and breast cancer: glycodynamics and functions

[1]  I. Brockhausen,et al.  UDP-Gal: GlcNAc-R β1,4-galactosyltransferase—a target enzyme for drug design. Acceptor specificity and inhibition of the enzyme , 2006, Glycoconjugate Journal.

[2]  Maureen E. Taylor,et al.  Two categories of mammalian galactose-binding receptors distinguished by glycan array profiling. , 2006, Glycobiology.

[3]  A. Nicolas,et al.  UDP-N-Acetyl-d-Galactosamine: Polypeptide N-Acetylgalactosaminyltransferase-6 as a New Immunohistochemical Breast Cancer Marker , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[4]  J. Taylor‐Papadimitriou,et al.  The ST6GalNAc-I Sialyltransferase Localizes throughout the Golgi and Is Responsible for the Synthesis of the Tumor-associated Sialyl-Tn O-Glycan in Human Breast Cancer* , 2006, Journal of Biological Chemistry.

[5]  E. Vadai,et al.  O‐glycosylated versus non‐glycosylated MUC1‐derived peptides as potential targets for cytotoxic immunotherapy of carcinoma , 2006, Clinical and experimental immunology.

[6]  A. Varki,et al.  Siglecs--the major subfamily of I-type lectins. , 2006, Glycobiology.

[7]  M. Zanetti,et al.  The Cooperation between Two CD4 T Cells Induces Tumor Protective Immunity in MUC.1 Transgenic Mice1 , 2005, The Journal of Immunology.

[8]  P. Crocker.  Siglecs in innate immunity. , 2005, Current opinion in pharmacology.

[9]  G. Courtand,et al.  Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration , 2005, Breast Cancer Research and Treatment.

[10]  I. Brockhausen,et al.  The effect of TNF-α on glycosylation pathways in bovine synoviocytes , 2004 .

[11]  I. Brockhausen,et al.  Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice. , 2004, International journal of oncology.

[12]  J. Taylor‐Papadimitriou,et al.  O-Linked Glycosylation in the Mammary Gland: Changes that Occur During Malignancy , 2001, Journal of Mammary Gland Biology and Neoplasia.

[13]  I. Brockhausen,et al.  Enzymatic basis for sialyl-Tn expression in human colon cancer cells , 1998, Glycoconjugate Journal.

[14]  M. Hanski,et al.  Fucosyltransferase III and sialyl-Lex expression correlate in cultured colon carcinoma cells but not in colon carcinoma tissue , 1996, Glycoconjugate Journal.

[15]  Michael A. Hollingsworth,et al.  Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.

[16]  M. Reddish,et al.  Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa , 2004, Glycoconjugate Journal.

[17]  J. Lowe,et al.  Glycan-dependent leukocyte adhesion and recruitment in inflammation. , 2003, Current opinion in cell biology.

[18]  S. Hirohashi,et al.  Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion. , 2003, Glycobiology.

[19]  I. Brockhausen.  Sulphotransferases acting on mucin-type oligosaccharides. , 2003, Biochemical Society transactions.

[20]  I. Brockhausen,et al.  Glycodynamics of mucin biosynthesis in gastrointestinal tumor cells. , 2003, Advances in experimental medicine and biology.

[21]  Lawrence A Tabak,et al.  All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. , 2003, Glycobiology.

[22]  R. Ahmed,et al.  Dynamic Regulation of T Cell Immunity by CD431 , 2002, The Journal of Immunology.

[23]  H. Itoh,et al.  Expression of UDP‐N‐acetyl‐α‐D‐galactosamine–polypeptide galNAc N‐acetylgalactosaminyl transferase‐3 in relation to differentiation and prognosis in patients with colorectal carcinoma , 2002, Cancer.

[24]  J. Lafitte,et al.  Tumor Necrosis Factor α Increases the Expression of Glycosyltransferases and Sulfotransferases Responsible for the Biosynthesis of Sialylated and/or Sulfated Lewis x Epitopes in the Human Bronchial Mucosa* , 2002, The Journal of Biological Chemistry.

[25]  J. Jass,et al.  Altered mucin expression in the gastrointestinal tract: a review , 2001, Journal of cellular and molecular medicine.

[26]  P. Schlag,et al.  Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas. , 2001, Cancer research.

[27]  I. Brockhausen,et al.  Pathways of Mucin O-Glycosylation in Normal and Malignant Rat Colonic Epithelial Cells Reveal a Mechanism for Cancer-Associated Sialyl-Tn Antigen Expression , 2001, Biological chemistry.

[28]  P. Schlag,et al.  Overexpression of Sialyltransferase CMP-Sialic Acid:Gal b 1,3GalNAc-R a 6-Sialyltransferase Is Related to Poor Patient Survival in Human Colorectal Carcinomas 1 , 2001 .

[29]  P. Schlag,et al.  Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases , 2000, Gut.

[30]  I. Brockhausen.  Pathways of O-glycan biosynthesis in cancer cells. , 1999, Biochimica et biophysica acta.

[31]  R. Poulsom,et al.  An α2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas , 1999 .

[32]  Y. Ikehara,et al.  Molecular mechanisms of expression of Lewis b antigen and other type I Lewis antigens in human colorectal cancer. , 1999, Glycobiology.

[33]  M. Hollingsworth,et al.  Control of O-Glycan Branch Formation , 1999, The Journal of Biological Chemistry.

[34]  下平 和久.  Carcinoma-associated expression of core 2 β-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer : role of O-glycans in tumor progression , 1999 .

[35]  M. Jakobsen,et al.  Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family. , 1999, Glycobiology.

[36]  I. Brockhausen,et al.  Glycoproteins and Their Relationship to Human Disease , 1998, Cells Tissues Organs.

[37]  Y. Furukawa,et al.  Single Glycosyltransferase, Core 2 β1→6-N-acetylglucosaminyltransferase, Regulates Cell Surface Sialyl-Lex Expression Level in Human Pre-B Lymphocytic Leukemia Cell Line KM3 Treated with Phorbolester* , 1998, The Journal of Biological Chemistry.

[38]  Y. Ikehara,et al.  Up-regulation of a set of glycosyltransferase genes in human colorectal cancer. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[39]  R. Kannagi,et al.  Gene expression of fucosyl- and sialyl-transferases which synthesize sialyl Lewisx, the carbohydrate ligands for E-selectin, in human breast cancer. , 1998, International journal of oncology.

[40]  E. Berger,et al.  Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus. , 1998, Journal of cell science.

[41]  M. Fukuda,et al.  Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression. , 1997, Cancer research.

[42]  R. Kannagi,et al.  Altered mRNA expression of specific molecular species of fucosyl‐ and sialyl‐transferases in human colorectal cancer tissues , 1997, International journal of cancer.

[43]  I. Brockhausen,et al.  Glycoproteins and Human Disease , 1997, Medical Intelligence Unit.

[44]  Y. Kim,et al.  Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. , 1996, Gastroenterology.

[45]  I. Brockhausen,et al.  Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. , 1995, European journal of biochemistry.

[46]  I. Brockhausen,et al.  Synthesis of O-glycan core 3: characterization of UDP-GlcNAc: GalNAc-R beta 3-N-acetyl-glucosaminyltransferase activity from colonic mucosal tissues and lack of the activity in human cancer cell lines. , 1995, Glycobiology.

[47]  E. Scanlon,et al.  T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced breast carcinoma. , 1995, Cancer detection and prevention.

[48]  R. Hill,et al.  Subcellular localization of the UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-mediated O-glycosylation reaction in the submaxillary gland. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[49]  I. Brockhausen,et al.  O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. , 1994, European journal of biochemistry.

[50]  E. Scanlon,et al.  T/Tn antigen vaccine is effective and safe in preventing recurrence of advanced human breast carcinoma. , 1994, Cancer biotherapy.

[51]  E. Bennett,et al.  Biosynthetic basis of incompatible histo-blood group A antigen expression: anti-A transferase antibodies reactive with gastric cancer tissue of type O individuals. , 1993, Cancer research.

[52]  T. Irimura,et al.  Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. , 1993, Cancer research.

[53]  C. Melief,et al.  Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction. , 1993, Journal of immunology.

[54]  F. Real,et al.  cis-Golgi resident proteins and O-glycans are abnormally compartmentalized in the RER of colon cancer cells. , 1993, Journal of cell science.

[55]  R. Zennadi,et al.  Involvement of histo‐blood‐group antigens in the susceptibility of colon carcinoma cells to natural killer‐mediated cytotoxicity , 1992 .

[56]  S. Itzkowitz,et al.  Mucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicity. , 1992, Cancer research.

[57]  K. Handa,et al.  Inhibition of selectin-dependent tumor cell adhesion to endothelial cells and platelets by blocking O-glycosylation of these cells. , 1992, Biochemical and biophysical research communications.

[58]  S. Hakomori,et al.  Induction of alpha-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice. , 1991, Cancer research.

[59]  I. Brockhausen,et al.  Control of mucin synthesis: the peptide portion of synthetic O-glycopeptide substrates influences the activity of O-glycan core 1 UDPgalactose:N-acetyl-alpha-galactosaminyl-R beta 3-galactosyltransferase. , 1990, Biochemistry.

[60]  S. Hakomori,et al.  Sialosyl‐Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients , 1990, Cancer.

[61]  M. Madej,et al.  Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate. , 1990, Cancer research.

[62]  H. Koprowski,et al.  Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. , 1983, Cancer research.